Skip to main content
Healthcare logoLink to Healthcare
. 2025 May 7;13(9):1088. doi: 10.3390/healthcare13091088

Prevalence of Erectile Dysfunction and Help-Seeking Behavior Among Patients Attending Primary Healthcare Centers for Non-Urological Complaints

Mansour Alnazari 1,*, Sulaiman Abdullah 2, Abdullah K Aljohani 2, Emad S Rajih 1, Ghadi S Alghamdi 3, Faris S Sebaa 4, Ali A Alraddadi 4, Wesam Khan 5, Adel Moalwi 6
Editor: Juan Carlos Sierra
PMCID: PMC12072084  PMID: 40361866

Abstract

Background/Objectives: Erectile dysfunction (ED) is a prevalent condition worldwide that significantly affects men’s sexual health and overall quality of life. ED is often associated with both psychological and organic factors and may serve as an early indicator of underlying health conditions such as diabetes mellitus, hypertension, and cardiovascular diseases. This study aimed to assess the attitudes and help-seeking behaviors of patients with ED who attended primary healthcare centers for non-urological reasons. Methods: A cross-sectional survey was conducted among 384 men aged 18 years and older who attended primary care clinics. Erectile dysfunction was evaluated using a structured questionnaire designed to assess patients’ attitudes toward ED, help-seeking behaviors, and treatment preferences. Results: Approximately half of the participants (49.5%) acknowledged the necessity of seeking treatment. However, the majority (53.1%) had not consulted specialized clinics, primarily due to social stigma and a preference for self-medication. Concerning sources of information on ED treatment, 30.7% of participants relied on their partners and healthcare providers. Conclusions: The study underscores critical barriers to ED management, including social stigma and reliance on self-medication, which may impede optimal treatment engagement and access to specialized care.

Keywords: erectile dysfunction, help-seeking behavior, Saudi Arabia

1. Introduction

Erectile dysfunction (ED) is a prevalent andrological condition that significantly impacts sexual health and quality of life [1]. It manifests as difficulty in achieving or maintaining an erection sufficient for sexual activity [2]. ED is a multifactorial condition resulting from complex interactions among biological, psychological, and social factors, such as vascular or neurological impairments, hormonal imbalances, performance anxiety, and tobacco use [3]. Consequently, ED serves as a potential indicator of underlying systemic diseases, such as diabetes mellitus, hypertension, and cardiovascular diseases [4]. Identifying the underlying cause of ED is essential for effective treatment, as it enables the management of both medical and psychosocial contributors [5].

Despite its high prevalence, a substantial proportion of individuals with ED do not seek medical care, and many healthcare providers hesitate to initiate discussions about sexual health due to cultural and social barriers. This lack of communication reduces quality of life and delays the diagnosis of more serious conditions that could contribute to increased morbidity and mortality [6]. Estimating the exact prevalence of ED is challenging, as it varies widely from 2% to 80% worldwide and has been reported at 10.53% among married men in Saudi Arabia [7,8]. Exploring patients’ attitudes and help-seeking behaviors is key to developing tailored treatment strategies that reflect the complex nature of ED [9].

Several studies suggest that phosphodiesterase type 5 inhibitors (PDE5Is) significantly improve erectile function. However, 20–30% of men experience unsatisfactory outcomes with oral PDE5Is [10]. While the majority of patients achieve satisfactory results, 31–57% discontinue treatment, often due to factors such as low educational levels and insufficient knowledge about ED and its management [11]. In addition, alternative treatment modalities such as intracavernosal injections, vacuum erection devices, and low-intensity shockwave therapy are also available, particularly for patients who are non-responsive to PDE5Is or for whom such medications are contraindicated.

The present study aimed to assess the attitudes of patients with ED toward their condition and available treatment options, as well as to investigate their help-seeking behaviors among individuals attending primary healthcare centers for non-urological complaint in Saudi Arabia.

2. Materials and Methods

2.1. Study Design and Setting

This cross-sectional study was conducted at public primary healthcare centers in Madinah, Saudi Arabia. The study aimed to assess the prevalence of ED and the associated help-seeking behaviors among men aged 18 years and older.

2.2. Study Population

The study included 384 men who visited primary care clinics. Participants were eligible if they were aged 18 years or older, attended the clinics during the study period from October to December 2023, and provided informed consent to participate.

2.3. Data Collection

Data were collected through a structured questionnaire, which was developed based on the study objectives and reviewed by experts in the field to ensure content validity. The questionnaire comprised sections on sociodemographic characteristics, lifestyle factors, medical history, and a validated Arabic version of the International Index of Erectile Function (IIEF-15); this version has been previously utilized in studies conducted among Saudi male populations [7,9]. The IIEF-15 assesses five domains: erectile function, orgasmic function, sexual desire, intercourse satisfaction, and overall satisfaction. Scores for each domain range from 0–5 or 1–5, with higher scores indicating better function. Sociodemographic data included age, education level, and monthly income. Lifestyle factors encompassed physical activity levels and smoking status. Medical history focused on common chronic conditions, including diabetes mellitus, hypertension, and hypercholesterolemia.

2.4. Statistical Analysis

Data were analyzed using IBM SPSS Statistics, version 26. Associations between erectile dysfunction and potential predictors were examined using the Chi-square test for categorical variables. Descriptive statistics were presented as percentages and frequencies. Statistical significance was defined as a p-value < 0.05 for all tests.

2.5. Ethical Considerations

Ethical approval for the study was obtained from the Institutional Review Board of General Directorate of Health Affairs in Madinah National Registration Number with NCBE-KACST, KSA: (H-03-M-84), IRB log No: 23-090 on 21 September 2023. Written informed consent was obtained from all participants before enrollment. Confidentiality and anonymity of participant data were strictly maintained throughout the study, with no personal identifiers recorded or reported.

3. Results

3.1. Study Population

A total of 384 men aged 18 years and older who attended primary healthcare centers in Madinah, Saudi Arabia, were enrolled in the study. The mean age of participants was 39 ± 8.5 years. A detailed breakdown of sociodemographic characteristics is provided in Table 1.

Table 1.

Sociodemographic characteristics, weight, exercise, and smoking status among participants (n = 384).

Parameter n Percentage (%)
Age group
(Mean ± SD = 39 ± 8.5)
≤34 109 28.4
35–45 105 27.3
45–55 90 23.4
>55 80 20.8
Number of children
(Mean ± SD = 3 ± 2)
0 29 7.6
1 50 13.0
2 92 24.0
3 82 21.4
4 69 18.0
>4 62 16.1
Number of wives 1 287 74.7
2 74 19.3
3 20 5.2
4 3 0.8
Education level No formal education 18 4.7
Primary 22 5.7
Intermediate 59 15.4
Secondary 129 33.6
University 156 40.6
Chronic diseases Hypertension 74 19.3
Diabetes mellitus 119 31.0
Hypercholesterolemia 54 14.1
Cardiovascular disease (e.g., stroke, angina) 23 6.0
Kidney failure 5 1.3
Mental illness 4 1.0
Neurological disorders 3 0.7
None 108 28.2
Weight (kg)
(Mean ± SD = 86.2 ± 15.7)
≤70 74 19.3
71–85 123 32.0
86–100 97 25.3
>100 90 23.4
Height (cm)
(Mean ± SD = 164.3 ± 8.9)
≤155 73 19.0
156–165 146 38.0
166–175 107 27.9
>175 58 15.1
Exercise frequency (per week) None 139 36.2
Once 102 26.6
2–3 times 78 20.3
4–5 times 38 9.9
≥6 times 27 7.0
Smoking status Cigarette smoker 89 23.2
Hookah smoker 148 38.5
Electronic cigarette user 61 15.9
Non-smoker 86 22.4

3.2. Prevalence of Erectile Dysfunction

As illustrated in Figure 1, 30.2% of participants reported that they were almost always able to achieve an erection, whereas 2.1% reported that they were almost never able to do so. Table 2 presents detailed responses regarding the ability to maintain an erection sufficient for penetration and during intercourse. Notably, 32.3% of participants reported always or almost always having an erection sufficient for penetration.

Figure 1.

Figure 1

Distribution of participants based on their ability to achieve an erection during sexual activity in the past four weeks. This figure illustrates the frequency with which participants reported being able to achieve an erection during sexual activity over the past month.

Table 2.

Participants’ attitudes towards ED over the past 4 weeks (n = 384).

Parameter n Percentage (%)
Frequency of achieving an erection during sexual activity No sexual activity 4 1.0
Almost always or always 116 30.2
Very often (much more than half the time) 129 33.6
Sometimes (about half the time) 88 22.9
Infrequently (much less than half the time) 39 10.2
Almost never or never 8 2.1
Frequency of having an erection strong enough for vaginal penetration No sexual arousal 5 1.3
Almost always or always 124 32.3
Very often (much more than half the time) 110 28.6
Sometimes (about half the time) 98 25.5
Rarely (much less than half the time) 35 9.1
Almost never or never 12 3.1
Frequency of successful penetration during intercourse I have never attempted intercourse 4 1.0
Almost always or always 118 30.7
Often (much more than half the time) 118 30.7
Sometimes (about half the time) 93 24.2
Rarely (much less than half the time) 42 10.9
Almost never or never 9 2.3
Frequency of maintaining an erection after penetration I have never attempted intercourse 4 1.0
Almost always or always 124 32.3
Often (much more than half the time) 108 28.1
Sometimes (about half the time) 94 24.5
Rarely (much less than half the time) 40 10.4
Almost never or never 14 3.6
Difficulty in maintaining an erection to complete intercourse I have never attempted intercourse 4 1.0
Very difficult 2 0.5
Difficult 54 14.1
Somewhat difficult 120 31.3
Mild difficulty 127 33.1
No difficulty 77 20.1
Confidence in achieving and maintaining an erection Very high 45 11.7
High 126 32.8
Medium 115 29.9
Low 82 21.4
Very low 16 4.2

3.3. Help-Seeking Behaviors and Treatment Outcomes

Despite the prevalence of ED symptoms, only 46.9% of participants had consulted a healthcare professional regarding their erectile difficulties (Figure 2). As reported in Table 3, the most common treatment modality was medical treatment (37.4%), followed by alternative approaches (34.3%) and self-directed methods (28.3%). Half of the study population (50.5%) perceived no need for treatment.

Figure 2.

Figure 2

Proportion of participants who consulted male clinics regarding ED. This figure shows the percentage of participants who sought consultation at specialized male clinics for erectile dysfunction and the percentage who did not.

Table 3.

Participants’ knowledge and awareness regarding ED treatment (n = 384), # the percentages in this table refer to the total number of responses (n = 176), not the total number of respondents.

Parameter n Percentage (%)
Sources of information about ED (Multiple responses allowed) (n = 176) # Friends 36 20.4
Wife 54 30.7
Doctor 54 30.7
Pharmacist 28 15.9
Social media 42 23.9
Perceived need for ED treatment Yes 190 49.5
No 194 50.5
Consultation at male clinics for ED Yes 180 46.9
No 204 53.1
Reasons for not seeking medical consultation (Multiple responses allowed) (n = 235) ED is not a serious condition 30 12.8
Reluctant to discuss ED due to social embarrassment 70 29.8
Not interested in sexual intercourse 100 26.0
Concerned about the harmful effects of medications 61 26.0
Satisfied with self-medication 73 31.0
Medications are available without a prescription 40 17.0
Use of medication for ED Yes 181 47.1
No 203 52.9
Preferred treatment modality (Multiple responses allowed) (n = 187) Medical treatment 70 37.4
Alternative treatments 64 34.3
Self-treatment 53 28.3
Sources of treatment information (n = 186) (Multiple responses allowed) * Friends 32 17.2
Wife 39 21.0
Doctor 52 28.0
Pharmacist 45 24.2
Social media 29 15.6
Perceived effectiveness of ED treatment (n = 191) No improvement 29 15.2
Slight improvement 46 24.1
Uncertain 57 29.8
Moderate improvement 35 18.3
Significant improvement 24 12.5
Perceptions of sexual enhancers (Viagra, Snafi) Safe 114 29.7
Unsafe 158 41.1
Uncertain 112 29.2
Reasons for considering sexual enhancers unsafe (Multiple responses allowed) (n = 268) * Risk of addiction or dependence 69 25.7
Serious side effects 79 29.5
Potential cardiovascular risks 74 27.6
Uncertain 69 25.7

* Results may overlap.

3.4. Associations with Sociodemographic and Lifestyle Factors

Chi-square analysis identified a significant association between age and medication use for ED (p = 0.019), with older participants more likely to use medication (Table 4). However, no significant associations were found between healthcare consultation and various sociodemographic factors (Table 5).

Table 4.

Association between taking medication for ED and sociodemographic characteristics.

Parameters Have You Ever Taken Medication for Erectile Dysfunction? Total (N = 384) p Value *
Yes No
Age group (years) ≤34 42 67 109 0.019
23.2% 33.0% 28.4%
34–45 45 60 105
24.9% 29.6% 27.3%
45 to 55 46 44 90
25.4% 21.7% 23.4%
>55 48 32 80
26.5% 15.8% 20.8%
Number of children 0 10 19 29 0.081
5.5% 9.4% 7.6%
1 21 29 50
11.6% 14.3% 13.0%
2 40 52 92
22.1% 25.6% 24.0%
3 36 46 82
19.9% 22.7% 21.4%
4 43 26 69
23.8% 12.8% 18.0%
>4 31 31 62
17.1% 15.3% 16.1%
Number of wives 1 129 158 287 0.282
71.3% 77.8% 74.7%
2 37 37 74
20.4% 18.2% 19.3%
3 13 7 20
7.2% 3.4% 5.2%
4 2 1 3
1.1% 0.5% 0.8%
Educational level No formal education 10 8 18 0.127
5.5% 3.9% 4.7%
Primary 13 9 22
7.2% 4.4% 5.7%
Intermediate 33 26 59
18.2% 12.8% 15.4%
Secondary 63 66 129
34.8% 32.5% 33.6%
University 62 94 156
34.3% 46.3% 40.6%
Diabetes or hypertension No 84 110 194 0.128
46.4% 54.2% 50.5%
Yes 97 93 190
53.6% 45.8% 49.5%
Smoking status Cigarette smoker 39 50 89 0.865
21.5% 24.6% 23.2%
Hookah smoker 70 78 148
38.7% 38.4% 38.5%
Electronic cigarette user 31 30 61
17.1% 14.8% 15.9%
Non-smoker 41 45 86
22.7% 22.2% 22.4%

* p-value was considered statistically significant if ≤0.05.

Table 5.

Association between consulting male clinics for ED and sociodemographic characteristics.

Parameters Have You Consulted Male Clinics Regarding Erectile Dysfunction? Total (N = 384) p Value *
Yes No
Age ≤34 54 55 109 0.235
30.0% 27.0% 28.4%
34–45 44 61 105
24.4% 29.9% 27.3%
45–55 38 52 90
21.1% 25.5% 23.4%
>55 44 36 80
24.4% 17.6% 20.8%
Number of children 0 13 16 29 0.394
7.2% 7.8% 7.6%
1 23 27 50
12.8% 13.2% 13.0%
2 35 57 92
19.4% 27.9% 24.0%
3 41 41 82
22.8% 20.1% 21.4%
4 38 31 69
21.1% 15.2% 18.0%
>4 30 32 62
16.7% 15.7% 16.1%
Number of wives 1 135 152 287 0.198
75.0% 74.5% 74.7%
2 31 43 74
17.2% 21.1% 19.3%
3 11 9 20
6.1% 4.4% 5.2%
4 3 0 3
1.7% 0.0% 0.8%
Educational level Uneducated 13 5 18 0.270
7.2% 2.5% 4.7%
Primary 11 11 22
6.1% 5.4% 5.7%
Intermediate 26 33 59
14.4% 16.2% 15.4%
Secondary 60 69 129
33.3% 33.8% 33.6%
University 70 86 156
38.9% 42.2% 40.6%
Diabetes or hypertension No 86 108 194 0.313
47.8% 52.9% 50.5%
Yes 94 96 190
52.2% 47.1% 49.5%
Smoking status Cigarette smoker 38 51 89 0.554
21.1% 25.0% 23.2%
Hookah smoker 76 72 148
42.2% 35.3% 38.5%
Electronic cigarette user 28 33 61
15.6% 16.2% 15.9%
Non-smoker 38 48 86
21.1% 23.5% 22.4%

* p-value was considered statistically significant if ≤0.05.

3.5. Knowledge and Awareness

A treatment uptake gap was observed, as only 47.1% of participants reported taking medication for ED. The primary sources of information about ED were doctors and spouses, each accounting for 30.7% of responses (Table 3). Concerns regarding the safety of sexual enhancers were prevalent, with 41.1% of participants perceiving them as unsafe due to potential adverse effects.

4. Discussion

Our findings underscore several critical aspects of ED among men in Madinah, Saudi Arabia, revealing a notable prevalence of ED and distinct variations in management and help-seeking behaviors. Approximately 30% of participants consistently achieved an erection sufficient for sexual activity; however, fewer than half sought professional consultation regarding their condition. It is important to recognize that ED prevalence varies by region and depends on the criteria and tools used for assessment. Although international studies report ED prevalence up to 52% in men aged 40–70 years [12,13], our findings showed lower rates of severe dysfunction. Only 2.1% of participants reported being almost never able to achieve an erection, while 10.2% did so infrequently. However, a large proportion reported partial difficulties (22.9% sometimes, and 33.6% very often), indicating that varying degrees of erectile issues are common. The inclusion of younger participants (28.4% under age 34) likely contributed to the lower rate of severe ED, yet 45.4% reported some level of difficulty maintaining erections, and only 11.7% expressed very high confidence. These findings highlight a significant burden of functional sexual concerns even in a relatively young population.

Erectile dysfunction is a multifactorial condition influenced by an intricate interplay of vascular, neurological, hormonal, and psychological factors. Vascular complications, particularly those arising from atherosclerosis and endothelial dysfunction, play a substantial role in the pathophysiology of ED and are frequently associated with systemic illnesses such as hypertension and diabetes [14]. Neurologically, conditions that impair nerve function or spinal integrity can disrupt the neural pathways required for normal erectile function [15]. In addition, testosterone levels significantly influence libido and erectile function, with hypogonadism being associated with a higher prevalence of ED [16]. Psychological factors such as depression, anxiety, and stress also contribute to both the onset and severity of ED, reinforcing its biopsychosocial nature [17]. The most common cause of ED, regardless of the age of the patient, is vasculogenic due to veno-occlusive dysfunction or venous leakage. However, the specific aging related ED is caused by gradual degradation and dysfunction of the corporal smooth muscle cells leading to the inability of the corporal tissue to prevent the blood from “leaking” out of the corporal sinusoids into the systemic veins. In addition, development of comorbidities such as hypertension and diabetes mellitus in aging males leads to various arterial diseases that contribute to ED [18]. We considered the need to take medication as a surrogate marker for the development of ED. In our study, increasing age was associated with the use of medication for ED. This observation was in agreement with previous reports from various parts of the world [19]. In another study in a Mediterranean country, the prevalence of severe ED increased from 2.7% in men in their twenties to 38.6% in their sixties and 46% in those aged 70 years and above. While age was the single most significant risk factor, other important risk factors included lower household income, physical inactivity, obesity, smoking, diabetes mellitus, hypertension, and ischemic heart disease [20]. In a previous study in Jeddah, Saudi Arabia, too, smoking was not considered as a risk factor for ED. However, patients with hypertension, diabetes mellitus, and ischemic heart disease had higher risk of developing a severe form of ED [21]. However, in our study, no statistically significant associations were found between ED and socio-demographic factors such as education level, number of wives, or chronic conditions like hypertension and diabetes mellitus, as detailed in Table 4 and Table 5 (p > 0.05). While these trends are noteworthy, no definitive conclusions can be drawn at this point. Further research with larger sample sizes and enhanced statistical power is necessary to verify or challenge these associations.

Although comorbidities such as diabetes, hypertension, and cardiovascular disease are well-established risk factors for erectile dysfunction [2,4], our findings showed that 28.2% of participants had no reported chronic medical conditions. Despite this, a considerable number within this subgroup reported varying degrees of erectile difficulty. This suggests that ED can occur even in the absence of organic disease and may reflect the influence of psychogenic or lifestyle-related factors. Psychological contributors such as anxiety, stress, and performance-related pressure have been recognized as key elements in younger men presenting with ED [8]. These findings emphasize the need for comprehensive assessment strategies that consider both organic and non-organic causes, even among seemingly healthy individuals.

By providing an expert opinion at any time, free of charge and in complete privacy, pharmacists play a pivotal part in promoting self-care interventions for sexual and reproductive health in the Eastern Mediterranean Region [22]. Among the participants in our study, 28% and 24% mentioned healthcare professionals including doctors and pharmacists and 21% mentioned wives as their major source of information. Earlier studies in western countries including the United Kingdom [23] and France [24] found that men sought help for sexual problems mostly from their sexual partners, followed by physicians. In more recent studies, the internet emerged as one of the most-consulted sources, and young patients tended to rely more on the internet [25,26]. In contrast, only about 15% of participants relied on social media as their internet-based source of information. The internet can be an important source of information for ED, especially for patients with a higher level of education and ability to search for and identify reliable content, whereas people with low health literacy may feel more comfortable navigating the readily accessible videos on social media such as YouTube. However, the scientific accuracy of information available on social media is often poor and untrustworthy. A recent study that assessed the scientific quality of Arabic-language video content related to erectile dysfunction highlighted that 84% of video content available on YouTube was not based on scientific evidence [27]. Therefore, for better health literacy around ED, it is not only important to popularize the use of the internet, but also to enable the users to access accurate content instead of relying on popularity-driven metrics.

Although the necessity of seeking treatment was acknowledged by half of the participants, the social stigma and a preference for self-medication inhibited half of the participants from reaching out to specialized clinics. The observed underutilization of ED healthcare services in our study is consistent with international evidence suggesting that stigma and cultural barriers significantly influence help-seeking behavior [28]. In terms of treatment approaches, medical therapy—mainly PDE5 inhibitors—was the most reported method, followed by using alternative and self-directed treatments. This trend reflects the findings of Albarakati et al., who reported a high rate of treatment dissatisfaction and discontinuation due to limited awareness and unrealistic expectations about pharmacological options [9]. Notably, surgical or device-based interventions were not reported in our sample, potentially indicating low access to or awareness of such modalities in the primary care context. In the Middle East and North Africa, there is a gap in culturally appropriate and accurate data regarding men’s sexual health, as conversation around sexuality is considered taboo or impolite [29]. A recent study reported that among Saudi laypersons, stigma plays a significant role in hindering the process of seeking psychological help for mental illness. However, the item on “Loss of sexual interest or pleasure” was removed from the Arabic version of Hopkins Symptom Checklist-25, aimed to measure anxiety and depression, as it was considered culturally inappropriate [30]. Thus, the perception was prevalent across social groups including healthcare professionals themselves. Most patients who have type 2 diabetes are not asked about ED within the last year of attendance, even though most are willing to discuss it with their physicians. A cross-sectional survey among Saudi men with type 2 diabetes revealed that older age and having more severe ED deterred patients from discussing their sexual health with their physicians. Moreover, even though most patients were willing to discuss it with their physicians, they were not asked about ED by the physicians within the last year of attendance [31]. Despite the availability of effective pharmacological treatments, including PDE5Is, our findings highlight substantial gaps in their utilization. This underutilization may stem from social stigmas, inadequate health literacy, and prevalent misconceptions regarding ED treatment options [32]. Furthermore, evidence suggests that a holistic approach to ED management, incorporating medical, psychological, and social interventions, is essential for optimizing patient outcomes [32,33]. Despite the high burden of sexual dysfunctions on their quality of life, men in the Middle East have limited access, low engagement, and low completion rates for treatment for sexual dysfunctions. Strategies for treatment should consider the sociocultural factors that influence treatment-seeking and engagement behaviors necessary for successful outcomes.

Although the necessity of seeking treatment was acknowledged by half of the participants, the social stigma and a preference for self-medication inhibited half of the participants from reaching out to specialized clinics. The observed underutilization of ED healthcare services in our study is consistent with international evidence, suggesting that stigma and cultural barriers significantly influence help-seeking behavior [9]. Moreover, the lack of health education, limited access to sexual health services, and digital misinformation contribute to further reluctance in seeking professional help. Misinformation, particularly from unreliable online sources, often leads to misconceptions about ED and its treatment options, delaying appropriate care.

To address these challenges, comprehensive strategies must be implemented. Public health initiatives should prioritize accessible, evidence-based education tailored to the sociocultural context. In parallel, there is an urgent need to strengthen the role of healthcare providers by equipping them with the knowledge and communication skills necessary to initiate discussions about sexual health. In conservative settings such as the Middle East, where conversations around sexual function are often avoided, clinician-led dialogue is especially critical. Previous studies have highlighted that reluctance among healthcare providers to address sexual concerns significantly hinders early diagnosis and appropriate management of ED [12,31]. Integrating structured training on sexual health into both undergraduate medical education and continuing professional development programs may improve clinician confidence, normalize patient–provider communication, and ultimately reduce the burden of untreated sexual dysfunction.

Limitations

The reliance on self-reported data may introduce response biases, potentially affecting the accuracy of findings. Additionally, the cross-sectional design of this study limits the ability to establish causal relationships between erectile dysfunction and associated factors. Furthermore, the generalizability of findings to other populations may be restricted due to the cultural specificity of the study sample. Additionally, body mass index (BMI) was not measured in this study, which limits the ability to assess the relationship between obesity and erectile dysfunction. Moreover, the potential influence of spousal or partner involvement on treatment-seeking behavior was not examined and represents a meaningful area for future investigation.

5. Conclusions

In conclusion, this study highlights the prevalence and management challenges of ED in the western region of Saudi Arabia, demonstrating substantial gaps between symptom burden and healthcare utilization. The findings emphasize the urgent need for culturally tailored public health initiatives to improve awareness, healthcare accessibility, and treatment engagement for ED in this population.

Author Contributions

Conceptualization, M.A. and E.S.R.; methodology, M.A., S.A., A.K.A., A.A.A., G.S.A. and F.S.S.; software, A.M.; validation A.M.; formal analysis, A.M.; investigation, S.A., G.S.A., F.S.S. and A.A.A.; resources, S.A., A.K.A., G.S.A., F.S.S. and A.A.A.; data curation, S.A., A.K.A., G.S.A., F.S.S. and A.A.A.; writing—original draft preparation, M.A., S.A. and A.M.; writing—review and editing, M.A., S.A. and A.M.; visualization, M.A., S.A. and A.M.; supervision, M.A., E.S.R., W.K. and A.M.; project administration, M.A., E.S.R., W.K. and A.M. All authors have read and agreed to the published version of the manuscript.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of General Directorate of Health Affairs in Madinah National Registration Number with NCBE-KACST, KSA: (H-03-M-84), IRB log No: 23-090 on 21 September 2023.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data are available and can be provided upon request.

Conflicts of Interest

The authors declare no conflicts of interest.

Funding Statement

This research received no external funding.

Footnotes

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

References

  • 1.Fisher W.A., Rosen R.C., Eardley I., Sand M., Goldstein I. Sexual experience of female partners of men with erectile dysfunction: The female experience of men’s attitudes to life events and sexuality (FEMALES) study. J. Sex. Med. 2005;2:675–684. doi: 10.1111/j.1743-6109.2005.00118.x. Erratum in J. Sex. Med. 2006, 3, 189. [DOI] [PubMed] [Google Scholar]
  • 2.Kessler A., Sollie S., Challacombe B., Briggs K., Van Hemelrijck M. The global prevalence of erectile dysfunction: A review. BJU Int. 2019;124:587–599. doi: 10.1111/bju.14813. [DOI] [PubMed] [Google Scholar]
  • 3.Hatzimouratidis K., Amar E., Eardley I., Giuliano F., Hatzichristou D., Montorsi F., Vardi Y., Wespes E., European Association of Urology Guidelines on male sexual dysfunction: Erectile dysfunction and premature ejaculation. Eur. Urol. 2010;57:804–814. doi: 10.1016/j.eururo.2010.02.020. [DOI] [PubMed] [Google Scholar]
  • 4.Raheem O.A., Su J.J., Wilson J.R., Hsieh T.C. The association of erectile dysfunction and cardiovascular disease: A systematic critical review. Am. J. Men’s Health. 2017;11:552–563. doi: 10.1177/1557988316630305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Hatzimouratidis K. Sildenafil in the treatment of erectile dysfunction: An overview of the clinical evidence. Clin. Interv. Aging. 2006;1:403–414. doi: 10.2147/ciia.2006.1.4.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Williams P., McBain H., Amirova A., Newman S., Mulligan K. Men’s beliefs about treatment for erectile dysfunction—What influences treatment use? A systematic review. Int. J. Impot. Res. 2021;33:16–42. doi: 10.1038/s41443-020-0249-1. [DOI] [PubMed] [Google Scholar]
  • 7.Alenezi T.M., Ahamed S.S., Almutairi H.R., Aleisa M.F., Alasmari M.M., Bagaies A.A., Albinhar T.H. Prevalence and the associated factors of erectile dysfunction among Saudi married males. Cureus. 2022;14:e30998. doi: 10.7759/cureus.30998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Simopoulos E.F., Trinidad A.C. Male erectile dysfunction: Integrating psychopharmacology and psychotherapy. Gen. Hosp. Psychiatry. 2013;35:33–38. doi: 10.1016/j.genhosppsych.2012.08.008. [DOI] [PubMed] [Google Scholar]
  • 9.Albarakati M., El-Tholoth H.S., Alzahrani A., Alghamdi O.S., Alquliti A., Alnuami M., Althobity A., Almardawi A., Bedaiwi K. Predictors of phosphodiesterase Type 5 inhibitor treatment failure in patients diagnosed with erectile dysfunction. Cureus. 2023;15:e50515. doi: 10.7759/cureus.50515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Kim S.C., Lee Y.S., Seo K.K., Jung G.W., Kim T.H. Reasons and predictive factors for discontinuation of PDE-5 inhibitors despite successful intercourse in erectile dysfunction patients. Int. J. Impot. Res. 2014;26:87–93. doi: 10.1038/ijir.2013.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Bivalacqua T.J., Usta M.F., Champion H.C., Kadowitz P.J., Hellstrom W.J. Endothelial dysfunction in erectile dysfunction: Role of the endothelium in erectile physiology and disease. J. Androl. 2003;24((Suppl. S6)):S17–S37. doi: 10.1002/j.1939-4640.2003.tb02743.x. [DOI] [PubMed] [Google Scholar]
  • 12.Al-Shaiji T.F. Breaking the ice of erectile dysfunction taboo: A focus on clinician-patient communication. J. Patient Exp. 2022;9:1–5. doi: 10.1177/23743735221077512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Sansone A., Guida E., Dolci S., Frangione V., Asso A., Bellia G., Jannini E.A. Future perspectives for PDE5 inhibitors bridging the gap between cardiovascular health and psychological status. Basic Clin. Androl. 2025;35:3. doi: 10.1186/s12610-024-00245-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Azadzoi K.M., Yang J., Siroky M.B. Neural regulation of sexual function in men. World J. Clin. Urol. 2013;2:32–41. doi: 10.5410/wjcu.v2.i3.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Rizk P.J., Kohn T.P., Pastuszak A.W., Khera M. Testosterone therapy improves erectile function and libido in hypogonadal men. Curr. Opin. Urol. 2017;27:511–515. doi: 10.1097/MOU.0000000000000442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Allen M.S., Wood A.M., Sheffield D. The psychology of erectile dysfunction. Curr. Dir. Psychol. Sci. 2023;32:487–493. doi: 10.1177/09637214231192269. [DOI] [Google Scholar]
  • 17.Çayan S., Kendirci M., Yaman Ö., Aşçı R., Orhan İ., Usta M.F., Ekmekçioğlu O., Kadıoğlu A. Prevalence of erectile dysfunction in men over 40 years of age in Turkey: Results from the Turkish Society of Andrology Male Sexual Health Study Group. Turk. J. Urol. 2017;43:122–129. doi: 10.5152/tud.2017.24886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Ferrini M.G., Gonzalez-Cadavid N.F., Rajfer J. Aging related erectile dysfunction-potential mechanism to halt or delay its onset. Transl. Androl. Urol. 2017;6:20–27. doi: 10.21037/tau.2016.11.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Pellegrino F., Sjoberg D.D., Tin A.L., Benfante N.E., Briganti A., Montorsi F., Eastham J.A., Mulhall J.P., Vickers A.J. Relationship Between Age, Comorbidity, and the Prevalence of Erectile Dysfunction. Eur. Urol. Focus. 2023;9:162–167. doi: 10.1016/j.euf.2022.08.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Ghalayini I.F., Al-Ghazo M.A., Al-Azab R., Bani-Hani I., Matani Y.S., Barham A.E., Harfeil M.N., Haddad Y. Erectile dysfunction in a Mediterranean country: Results of an epidemiological survey of a representative sample of men. Int. J. Impot. Res. 2010;22:196–203. doi: 10.1038/ijir.2009.65. [DOI] [PubMed] [Google Scholar]
  • 21.Bogari M., Alzahrani B.A., Aghashami A.S., Alsubeay A.M.S., Hassan F., Ahmed M.E., Almuqati M.M. Male Sexual Dysfunction-Related Medical Comorbidities in a Tertiary Care Center, Western Region, Saudi Arabia. Cureus. 2023;15:e41732. doi: 10.7759/cureus.41732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.El Bizri L., Jarrar L.G., Ali W.K.A., Omar A.H. The role of community pharmacists in increasing access and use of self-care interventions for sexual and reproductive health in the Eastern Mediterranean Region: Examples from Egypt, Jordan, Lebanon and Somalia. Health Res. Policy Syst. 2021;19((Suppl. S1)):49. doi: 10.1186/s12961-021-00695-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Moreira E.D., Glasser D.B., Nicolosi A., Duarte F.G., Gingell C., GSSAB Investigators’ Group Sexual problems and help-seeking behaviour in adults in the United Kingdom and continental Europe. BJU Int. 2008;101:1005–1011. doi: 10.1111/j.1464-410X.2008.07453.x. [DOI] [PubMed] [Google Scholar]
  • 24.Buvat J., Glasser D., Neves R.C., Duarte F.G., Gingell C., Moreira E.D., Jr., Global Study of Sexual Attitudes and Behaviours (GSSAB) Investigators’ Group Sexual problems and associated help-seeking behavior patterns: Results of a population-based survey in France. Int. J. Urol. 2009;16:632–638. doi: 10.1111/j.1442-2042.2009.02316.x. [DOI] [PubMed] [Google Scholar]
  • 25.Zhang K., Yu W., He Z.J., Jin J. Help-seeking behavior for erectile dysfunction: A clinic-based survey in China. Asian J. Androl. 2014;16:131–135. doi: 10.4103/1008-682X.122350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Zarski A.C., Velten J., Knauer J., Berking M., Ebert D.D. Internet- and mobile-based psychological interventions for sexual dysfunctions: A systematic review and meta-analysis. NPJ Digit. Med. 2022;5:139. doi: 10.1038/s41746-022-00670-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Alzahrani M.A., Khan M.A., Hakami B.O., Alahmadi A., Alzahrani M., Alsaleh F., Almurayyi M., Safar O., Ahmad M.S. Is Arabic Information on YouTube About Erectile Dysfunction Based on Scientific Evidence? Res. Rep. Urol. 2023;15:261–272. doi: 10.2147/RRU.S410127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Saffati G., Seyan Z., Rendon D.O., Almuhaideb M., Hinojosa-Gonzalez D.E., Kronstedt S., Khera M. Erectile dysfunction as a holistic indicator of well-being: A narrative review. Sex. Med. Rev. 2025;13:11–19. doi: 10.1093/sxmrev/qeae066. [DOI] [PubMed] [Google Scholar]
  • 29.El Ansari W., El-Ansari K., Arafa M. Breaking the silence—Systematic review of the socio-cultural underpinnings of men’s sexual and reproductive health in Middle East and North Africa (MENA): A handful of taboos? Arab. J. Urol. 2024;23:16–32. doi: 10.1080/20905998.2024.2387511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Alluhaibi B.A., Awadalla A.W. Attitudes and stigma toward seeking psychological help among Saudi Adults. BMC Psychol. 2022;10:216. doi: 10.1186/s40359-022-00923-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Almigbal T.H., Schattner P. The willingness of Saudi men with type 2 diabetes to discuss erectile dysfunction with their physicians and the factors that influence this. PLoS ONE. 2018;13:e0201105. doi: 10.1371/journal.pone.0201105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Brotto L.A., Atallah S., Carvalho J., Gordon E., Pascoal P.M., Reda M., Stephenson K.R., Tavares I.M. Psychological and interpersonal dimensions of sexual function and dysfunction: Recommendations from the fifth international consultation on sexual medicine (ICSM 2024) Sex. Med. Rev. 2024;13:118–143. doi: 10.1093/sxmrev/qeae073. [DOI] [PubMed] [Google Scholar]
  • 33.Atallah S., Haydar A., Jabbour T., Kfoury P., Sader G. The effectiveness of psychological interventions alone, or in combination with phosphodiesterase-5 inhibitors, for the treatment of erectile dysfunction: A systematic review. Arab. J. Urol. 2021;19:310–322. doi: 10.1080/2090598X.2021.1926763. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data are available and can be provided upon request.


Articles from Healthcare are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES